SS 11 - Bio 2: Experimental Therapeutics

Moderator(s)

• 

  Quaovi Sodji, MD, PhD

  University of Wisconsin School of Medicine and Public Health
  Madison, WI
• SK

  Sunil Krishnan, MD, PhD, FASTRO

  UT Health Science Center at Houston
  Houston, TX, United States

Presentations:

• 8:00 AM – 8:10 AM ET

  Convection-Enhanced Drug Delivery and Radiosensitization for Diffuse Midline Glioma
  

  Presenter: Matthew Gallitto, MD, PhD – Columbia University Irving Medical Center
• 8:10 AM – 8:20 AM ET

  Exploring the Combined Effects of Tamoxifen and Radiotherapy, Regardless of Estrogen Receptor Status
  

  Presenter: Shuangshuang Ma, MS
• 8:20 AM – 8:30 AM ET

  A Precision Oncology Platform to Target CDK4/6 Inhibitor Resistance
  

  Presenter: Kamal Pandey, PhD – UT Southwestern Medical Center at Dallas
• 8:30 AM – 8:40 AM ET

  Novel Radiosensitizer Screen Identifies an Effective Strategy to Treat p53 Wild-Type Breast Cancer Models in a Hormone Independent Manner
  

  Presenter: Reine Abou Zeidane, MD – Case Western Reserve School of Medicine
• 8:40 AM – 8:50 AM ET

  Synergistic Potential of CDK4/6 Inhibitors and Radiotherapy with Anti-PD-L1 Immunotherapy in Triple-Negative Breast Cancer
  

  Presenter: Wen-Chi Yang, MD – National Taiwan University Hospital
• 8:50 AM – 9:00 AM ET

  Discussant
  

  Discussant: Nadeem Riaz, MD, MS – Memorial Sloan Kettering Cancer Center